Eiger Mountains
Webcast ImageWebcast
Eiger hosted Analyst / KOL event: Developing a Treatment for Post-Bariatric Hypoglycemia (Live)
12/09/16 at 8:00 a.m. ET
Eiger hosted Analyst / KOL event: Developing a Treatment for Post-Bariatric Hypoglycemia
Friday, December 9, 2016 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
Eiger is a clinical-stage biopharmaceutical company committed to developing and commercializing novel products for the treatment of Orphan diseases. Eiger has built a diverse, late-stage portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, a novel biology for treatment has been identified, and for which an effective therapy is urgently needed. The Eiger management team has extensive experience in the clinical development... More >>
Stock Quote
EIGR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$11.70
Change (%) Stock is Down 0.15 (1.27%)
Volume13,110
Data as of 12/02/16 4:00 p.m. ET
Refresh quote
Recent NewsMore >>
DateTitle
11/29/16Eiger Updates Progress in Clinical Development Program for Exendin 9-39 to Treat Post-Bariatric Hypoglycemia (PBH)
11/21/16Eiger BioPharmaceuticals to Participate in Two Investor Conferences in November 2016
11/14/16Eiger Announces Additional LOWR HDV Program Data, Clinical and Regulatory Plans at the American Association for the Study of Liver Diseases (AASLD) Meeting
11/14/16Eiger Announces Positive Phase 2 Data at the American Association for the Study of Liver Diseases (AASLD) Meeting: Multiple Paths Forward Identified with Lonafarnib Therapy in LOWR HDV Program
Upcoming EventsMore >>
DateTitle
12/09/16 8:00 a.m. ET
Eiger hosted Analyst / KOL event: Developing a Treatment for Post-Bariatric Hypoglycemia
01/09/17
through
01/12/17
Eiger BioPharmaceuticals at J.P. Morgan 35th Annual Healthcare Conference 2017 San Francisco
LocationSan Francisco, CA
What's New
There are currently no items available.
Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Eiger BioPharmaceuticals posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.